| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Repligen 136 | CTRPv2 | pan-cancer | AAC | 0.073 | 0.06 |
| mRNA | PF-184 | CTRPv2 | pan-cancer | AAC | 0.066 | 0.06 |
| mRNA | QL-XI-92 | GDSC1000 | pan-cancer | AAC | -0.057 | 0.06 |
| mRNA | neopeltolide | CTRPv2 | pan-cancer | AAC | 0.14 | 0.06 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | 0.062 | 0.06 |
| mRNA | CEP-701 | GDSC1000 | pan-cancer | AAC | 0.061 | 0.06 |
| mRNA | ZSTK474 | GDSC1000 | pan-cancer | AAC | -0.057 | 0.07 |
| mRNA | BRD8958 | CTRPv2 | pan-cancer | AAC | 0.076 | 0.07 |
| mRNA | FH535 | GDSC1000 | pan-cancer | AAC | 0.063 | 0.07 |
| mRNA | VX-702 | GDSC1000 | pan-cancer | AAC | -0.064 | 0.07 |